VTN and COVID-19: Some significant concerns have been raised concerning the side effects of convalescent plasma in COVID-19, such as transfusion-associated circulatory overload, the infusion of complement proteins and coagulation factors to circulatory system and antibody-dependent enhancement of COVID-19 disease [35].